Genmab — Juni 2013
-
http://freedmanpatent.com/images/Proceedings_Freedman_Final.pdf lidt optakt til rrms forsøget
-
-
Vi har haft den oppe at vende for 10dage siden. Udover effekten h
æfter mig ved at bivirkninger klares med antihistamin og panodil! (ingen prednisolon) -
hæfter jeg mig, skulle der stå
-
en god nyhed kan man ikke få for tit. Så keep ém coming
-
Den milde "infusions"reaktion gør det super velegnet til ambulant behandling.
-
Schotman was diagnosed with myeloma close to six years ago, right around the time of his forty-eighth birthday. After undergoing two transplants involving blood-forming stem cells and multiple drug therapies, only to have his cancer bounce back time and again, he signed up for Plesner's and Richardson's ongoing trial earlier this year. In February, he weaned off all of his drugs, and every Wednesday this spring he traveled three hours from his home in the northern Netherlands to the University
-
-
Nice: We are very hopeful that daratumumab will be a great dance partner with our other drugs,” Richardson says.
-
-
gen åbner i plus - det er lige før jeg falder ned af stolen
-
det må du nok sige. Det er ikke helt til at gennemskue, hvad der sker i GEN lige nu
-
det kan have noget at gøre med den diskussion, som greatrosser startede på EI i går aftes
-
på ingen måder - jeg siger bare, at han måske har fat i noget, som vi ikke lige har behandlet her. Nemlig tallet for Hazard ratio, som virker lidt uldent - specielt fordi kontrolarmene i ga101 og rituxan studierne er nogenlunde sammenlignelige
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind